Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Market Cap	30.04B
Revenue (ttm)	7.07B
Net Income (ttm)	1.47B
Shares Out	111.93M
EPS (ttm)	13.16
PE Ratio	20.39
Forward PE	17.77
Dividend	5.20 (1.91%)
Ex-Dividend Date	n/a

Volume	102,336
Average Volume	143,934
Open	272.20
Previous Close	271.95
Day's Range	266.35 - 275.10
52-Week Range	257.90 - 366.25
Beta	0.39
RSI	30.16
Earnings Date	Jan 31, 2026

About NSE:ADVENZYMES

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1957
• Employees: 338
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ADVENZYMES

Financial Performance

In 2024, NSE:ADVENZYMES's revenue was 6.37 billion, an increase of 2.09% compared to the previous year's 6.24 billion. Earnings were 1.31 billion, a decrease of -1.64%.